About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
DELIVERABLE VOLUME
Deliverable
Volume
Sun Pharmaceutical Industries Ltd.
BSE Code
524715
ISIN Demat
INE044A01036
Book Value
101.44
NSE Code
SUNPHARMA
Dividend Yield %
0.96
Market Cap
4008089.07
P/E
93.59
EPS
17.85
Face Value
1
Exchange :
BSE
NSE
Period From :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Period To :
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
DEC
2025
2024
Date
Total Volume
Deliverable Volume
Deliverable Volume [%]
25-Jun-2025
68293
53187
77.88
24-Jun-2025
142834
64292
45.01
23-Jun-2025
22752
14727
64.73
20-Jun-2025
16173
7383
45.65
19-Jun-2025
17742
7555
42.58
18-Jun-2025
77241
52357
67.78
17-Jun-2025
557292
66236
11.89
16-Jun-2025
167353
18023
10.77
13-Jun-2025
42174
8348
19.79
12-Jun-2025
103667
41930
40.45
11-Jun-2025
25864
12108
46.81
10-Jun-2025
135710
21480
15.83
09-Jun-2025
109346
71393
65.29
06-Jun-2025
46947
20909
44.54
05-Jun-2025
59001
25555
43.31
04-Jun-2025
80805
55912
69.19
03-Jun-2025
115411
24127
20.91
02-Jun-2025
141144
120285
85.22
Page
1
of
1
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.